Abstract 110P
Background
Nasopharyngeal carcinoma (NPC) is a squamous cell carcinoma with high metastatic propensity and is often diagnosed at advanced stages, raising public health concerns in its endemic regions such as South China and Southeast Asia. The study of NPC metastasis is hindered by the lack of appropriate models capable to recapitulate the heterogeneous tumour microenvironment in vitro. The current study aims to generate an in vitro model to represent the in vivo biology for NPC and characterize the spheroid invasion in real time.
Methods
To mimic the microenvironment encountered by NPC cells in vivo, heterotypic multicellular tumour spheroids (MCTSs) consisting of triple co-culture of NPC cells (HK-1), fibroblasts (MRC-5), and endothelial cells (HUVEC) was generated using a scaffold-based method. Through histological and immunofluorescence analyses, the morphological characteristic and the organization of the MCTSs were characterized. Tumour spheroid migration assays were conducted on the extracellular matrix (ECM). Quantitative real-time measurements of migration and invasion through an ECM barrier of the MCTSs were conducted by using a real-time cell analyser.
Results
Heterotypic MCTSs constituted from HK-1, MRC-5, and HUVEC formed irregular mass and stellate morphology structure, with loosely arranged cells observed as revealed by H&E staining. The cells demonstrated tumour features including high chromatic and pleomorphism, high nuclear-to-cytoplasmic ratio, mitosis, and necrosis. Immunofluorescence staining showed the presence of NPC cells, fibroblasts, and endothelial cells in the heterotypic MCTSs. Through real-time cell monitoring, this heterotypic MCTSs showed migration and invasion at 1:10 Matrigel with 0.5 μg/μl fibronectin.
Conclusions
The three-dimensional model generated in this study successfully reconstructed the in vivo biology of NPC. To our knowledge, this is the first report on NPC spheroid model that incoporate both tumour and stromal cells. 3D co-culture spheroid is holding a great promise as next generation standard of in vitro pre-clinical model for biomarkers discovery, accelerating drug screening process, and achieving a more precise personalized treatment for cancer patients.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Fundamental Research Grant Scheme FRGS (FGRS/1/2020/SKK0/UCSI/02/2) by Ministry of Higher Education (MOHE) Malaysia.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
30P - Role of microRNA and CDKN2A/p16INK4a expression in the prognostication of oral squamous cell carcinoma
Presenter: Olha Burtyn
Session: Cocktail & Poster Display session
Resources:
Abstract
31P - Identification of proteins associated with mRNA processing and maturation by quantitative proteomic analysis in Indian cervical cancer patients
Presenter: Amrita Mukherjee
Session: Cocktail & Poster Display session
Resources:
Abstract
32P - Expression of STAT3 and hypoxia markers in repeatedly resected glioma patients
Presenter: Katerina Dvorakova
Session: Cocktail & Poster Display session
Resources:
Abstract
33P - Unraveling the mechanisms of cisplatin resistance in bladder organoid by single cell RNA sequencing
Presenter: Tingting Xie
Session: Cocktail & Poster Display session
Resources:
Abstract
34P - Functional diagnostics and ex-vivo screening of erlotinib and nintedanib in non-small cell lung carcinoma: Implications for multidrug resistance and personalized therapy
Presenter: Jelena Dinić
Session: Cocktail & Poster Display session
Resources:
Abstract
35P - Enhancing efficacy of the MEK inhibitor trametinib in KRAS-mutated colorectal cancer cells
Presenter: Lee Ellis
Session: Cocktail & Poster Display session
Resources:
Abstract
36P - Comparison of pelitinib, tepotinib or docetaxel efficacy according to the copy number or gene alteration status of EGFR, MET, HRAS, KRAS and NRAS genes
Presenter: Dae Young Zang
Session: Cocktail & Poster Display session
Resources:
Abstract
37P - NET-mediated radio-resistance in early-stage non-small cell lung cancer
Presenter: Malcolm Ryan
Session: Cocktail & Poster Display session
Resources:
Abstract
39P - The use of antibiotics or proton pump inhibitors and the response to intravesical Bacillus Calmette Guérin therapy in non-muscle-invasive bladder cancer
Presenter: João Barbosa Martins
Session: Cocktail & Poster Display session
Resources:
Abstract
40P - YAP1 promotes sorafenib resistance by activation of TGFβ signaling pathway
Presenter: Chit Lai Chee
Session: Cocktail & Poster Display session
Resources:
Abstract